From: Thyroid hormones and functional outcomes after ischemic stroke
TSH | fT3 | fT4 | |
---|---|---|---|
Discharge outcomes | |||
Death in hospital | NS | NS | |
Died | 0.5245 (0.303–0.761)* | ||
Alive | 1.275 (0.75–1.9875)* | ||
Death in hospital or hospice vs alive | NS | NS | |
Death or hospice | 1.99 (1.74–2.475)* | ||
Alive | 2.47 (2.13–2.95)* | ||
3 month outcomes | |||
Death vs alive at 3 months | NS | NS | |
Death | 0.66 (0.372–1.45)* | ||
Alive | 1.27 (0.75–2.11)* | ||
Independence level | NS | NS | |
mBI > 15, independent | 2.53 (2.24–2.99)** | ||
mBI < 14, dependent | 2.06 (1.85–2.6)** | ||
Poor outcome, mRS > 3 or death | 0.873 (0.586–1.48)* | ||
Favourable outcome, mRS < 2 | 1.54 (0.6575–2.255)* | ||
12 month outcomes | |||
mRS score | NS | R = −0.268* | NS |
mBI > 15, independent | 2.525 (2.26–2.965)* | ||
mBI < 14, dependent | 2.175 (1.865–2.823)* | ||
Poor outcome, mRS > 3 or death | 2.04 (1.825–2.485)*** | ||
Favourable outcome, mRS < 2 | 2.62 (2.32–2.97)*** |